ctrl K

Advertisement

enGene Inc. Warrants (ENGNW)

NASDAQ: ENGNW · Real-Time Price · USD

0.71

0.00 (0.00%)

At close: Apr 28, 2025, 2:28 PM

enGene Warrants Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	175K	n/a	n/a	n/a
Gross Profit	n/a	-175K	n/a	n/a	n/a
Operating Income	62.3M	-26.06M	-19.43M	-15.87M	-13.85M
Interest Income	-10.41M	1.12M	129K	25K	56K
Pretax Income	55.16M	-99.9M	-24.44M	-23.44M	-15.07M
Net Income	55.14M	-99.92M	-24.46M	-23.44M	-15.07M
Selling & General & Admin	23.98M	9.43M	3.26M	3.15M	3.24M
Research & Development	38.31M	16.46M	15.47M	12.46M	10.61M
Other Expenses	n/a	n/a	-393K	-128K	636K
Operating Expenses	62.3M	25.89M	19.43M	15.87M	13.85M
Interest Expense	2.8M	4.95M	1.42M	5.02M	3.7M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	26.06M	19.43M	15.87M	13.85M
Income Tax Expense	-19K	17K	22K	4.9M	4.33M
Shares Outstanding (Basic)	509.77M	23.56M	15.81M	15.81M	15.81M
Shares Outstanding (Diluted)	509.77M	23.56M	15.81M	15.81M	15.81M
EPS (Basic)	0.15	-4.24	-1.55	-1.48	-0.95
EPS (Diluted)	0.15	-4.24	-1.55	-1.48	-0.95
EBITDA	62.3M	-94.77M	-19.45M	-15.7M	-12.9M
EBIT	57.96M	-94.95M	30.73K	-225.44K	-7.73M
Depreciation & Amortization	n/a	175K	238K	272K	259K